NCT00393549

Brief Summary

The purpose of the study is to compare the performance of the NeuroPath automated nerve conduction test with the standard of care manual test in the diagnosis of entrapment neuropathies.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Aug 2006

Shorter than P25 for phase_3

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2006

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

October 27, 2006

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 30, 2006

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2006

Completed
Last Updated

June 6, 2007

Status Verified

June 1, 2007

First QC Date

October 27, 2006

Last Update Submit

June 5, 2007

Conditions

Keywords

Median Neuropathy at the wrist (MNW)

Outcome Measures

Primary Outcomes (1)

  • Validity of the NeuroPath

Secondary Outcomes (1)

  • Accuracy of the NeuroPath

Interventions

NeuroPathDEVICE

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Sensory symptoms (numbness and/or tingling) aggravated by at least 1 of the following: sleep, sustained hand or arm positioning, or repetitive actions of the hand.
  • Sensory symptoms (numbness and/or tingling) mitigated by at least 1 of the following: changes in hand posture, shaking the hand, or use of a wrist splint.
  • If pain is present, the wrist, hand, and finger pain is greater than elbow, shoulder, or neck pain if there is pain in any or all of those locations.

You may not qualify if:

  • Sensory symptoms exclusive or predominatly in the little finger (D5) (ulnar neuropathy).
  • Neck pain or shoulder pain preceded the paresthesia in the digits (cervical radiculopathy and/or brachial plexopathy).
  • Numbness and/or tingling in the feet that preceded or accompanied the sensory symptoms in the hands (polyneuropathy).
  • Medical history and physical examination that indicates an explanation for the sensory symptoms which is more probable than CTS. For example, digital neuropathy, median nerve pathology proximal to the carpal tunnel, ulnar neuropathy, radical neuropathy, brachial plexopathy, cervical radiculopathy, spinal cord, brainstem or brain pathology, or a polyneuropathy.
  • Absence of 1st, 3rd, 4th or 5th digits
  • Open wounds at the measurement sites
  • Excessive sensitivity to electrical stimulation
  • Median nerve injection in the past 30 days
  • Prior carpal tunnel surgery
  • Patients who are susceptible to radio frequency noise - such as patients with pacemakers or patients that have electrical stimulators of any sort.
  • Normal neurological examination
  • Absence of 1st, 3rd or 5th digits
  • Open wounds at the measurement sites
  • Excessive sensitivity to electrical stimulation
  • Median nerve injection in the past 30 days
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Harmonex Neuroscience Research

Dothan, Alabama, 36303, United States

Location

SunCoast Neuroscience Associateion

St. Petersburg, Florida, 33701, United States

Location

MeSH Terms

Conditions

Carpal Tunnel Syndrome

Condition Hierarchy (Ancestors)

Median NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNerve Compression SyndromesCumulative Trauma DisordersSprains and StrainsWounds and Injuries

Study Officials

  • Ron Kurtz

    Excel-Tech Ltd. (XLTEK)

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

October 27, 2006

First Posted

October 30, 2006

Study Start

August 1, 2006

Study Completion

December 1, 2006

Last Updated

June 6, 2007

Record last verified: 2007-06

Locations